Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - MabVax

  • Pancreatic Cancer Imaging Agent Earns MabVax $1.75M SBIR Award
    MabVax Therapeutics has received a contract from the National Cancer Institute under the ... MabVax discovered the 5B1 anti-sialyl-Lewis a (sLe a ) antibody from a patient who was ...
    9-24-2013
  • GEN | Biolinks
    ... Lumigen -- a Wholly Owned Subsidiary pof Beckamn Coulter Luminex M2P-Labs MabVax Therapeutics, Inc. MacroGenics, Inc Madeira Therapeutics, LLC Magyosz - Hungarian Pharmaceutical ...
  • NCI Grants MabVax $150K for Neuroblastoma Vaccine
    MabVax Therapeutics received an SBIR grant from the NCI. The initial grant award of ... been completed with promising results in a limited number of patients, MabVax reports. ...
    12-18-2012
  • Top 20 Venture Capital Firms
    ... Biosciences, Captaris Therapeutics, Chromatin, Lentigen, Logical Therapeutics, MabVax Therapeutics, Neos Therapeutics, Neurotech, Newbridge Pharmaceuticals, Nora ...
    12-17-2012
  • MabVax Wins $1.8M SBIR Grant to Support Phase II Sarcoma Vaccine...
    MabVax Therapeutics has received a $1.8 million Phase 2 SBIR grant from the NCI to support ... MabVax was founded to exploit MSKCC's approach to the development of cancer vaccines ...
    4-11-2011
  • MabVax Licenses Cancer Vaccine Technology from Sloan-Kettering
    MabVax Therapeutics inked two licensing agreements with the Sloan-Kettering Institute for Cancer Research (SKI)www.mskcc.org. The first deal grants MabVax exclusive development and ...
    8-12-2008

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll